|
WO2012024361A1
|
|
Commercial scale production methods for transdermal hormone formulations
|
|
EP2385062A2
|
|
Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
|
|
US2008279831A1
|
|
Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
|
|
US2008014222A1
|
|
Cancer immunotherapy compositions and methods of use
|
|
US2007059820A1
|
|
Methods to express recombinant proteins from lentiviral vectors
|
|
EP1811941A2
|
|
Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
|
WO2006073503A1
|
|
Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
|
|
WO2005099668A2
|
|
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
EP2574346A1
|
|
Cytokine-expressing cellular vaccine combinations
|
|
AU2003287726A1
|
|
Intraocular delivery compositions and methods
|
|
EP1418939A2
|
|
Calcium phosphate particles as mucosal adjuvants
|
|
IL156920D0
|
|
Therapeutic agents complexed with calcium phosphate and encased by casein
|
|
EP1471034A2
|
|
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
IL144084D0
|
|
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
US6183803B1
|
|
Method for processing milk
|
